Elevance Health reports $50.4B in third-quarter operating revenue, raises full-year guidance

Elevance Health said in a company press release dated Oct. 20, 2026 that operating revenue for the third quarter of 2026 was $50.4 billion and that it raised its full-year 2026 guidance: diluted EPS to at least $22.00, adjusted diluted EPS to at least $29.00 and operating cash flow to at least $6.5 billion.

The company reported third-quarter diluted earnings per share of $6.27 and adjusted diluted EPS of $6.99; the results reflected a net non-operating benefit of $1.85 per share, per the release. Operating cash flow was $1.3 billion in the quarter, an increase of $0.1 billion versus the prior year quarter, the company said. Elevance described results as ahead of expectations in the release itself. (Company statement.)

Report a correction · Editorial standards · Our source directory

BusinessIndy examines this development and its implications for Indiana businesses and communities using the linked sources.

Continued verification is in progress.